1. Home
  2. OLMA vs VLY Comparison

OLMA vs VLY Comparison

Compare OLMA & VLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • VLY
  • Stock Information
  • Founded
  • OLMA 2006
  • VLY 1927
  • Country
  • OLMA United States
  • VLY United States
  • Employees
  • OLMA N/A
  • VLY N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • VLY Major Banks
  • Sector
  • OLMA Health Care
  • VLY Finance
  • Exchange
  • OLMA Nasdaq
  • VLY Nasdaq
  • Market Cap
  • OLMA 378.9M
  • VLY 5.2B
  • IPO Year
  • OLMA 2020
  • VLY N/A
  • Fundamental
  • Price
  • OLMA $8.00
  • VLY $10.65
  • Analyst Decision
  • OLMA Strong Buy
  • VLY Buy
  • Analyst Count
  • OLMA 5
  • VLY 12
  • Target Price
  • OLMA $24.00
  • VLY $11.75
  • AVG Volume (30 Days)
  • OLMA 1.0M
  • VLY 7.5M
  • Earning Date
  • OLMA 11-11-2025
  • VLY 10-23-2025
  • Dividend Yield
  • OLMA N/A
  • VLY 4.14%
  • EPS Growth
  • OLMA N/A
  • VLY 9.10
  • EPS
  • OLMA N/A
  • VLY 0.78
  • Revenue
  • OLMA N/A
  • VLY $1,603,358,000.00
  • Revenue This Year
  • OLMA N/A
  • VLY $33.98
  • Revenue Next Year
  • OLMA N/A
  • VLY $8.90
  • P/E Ratio
  • OLMA N/A
  • VLY $13.63
  • Revenue Growth
  • OLMA N/A
  • VLY N/A
  • 52 Week Low
  • OLMA $2.86
  • VLY $7.48
  • 52 Week High
  • OLMA $13.93
  • VLY $11.10
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 68.75
  • VLY 65.05
  • Support Level
  • OLMA $7.22
  • VLY $10.66
  • Resistance Level
  • OLMA $8.25
  • VLY $10.94
  • Average True Range (ATR)
  • OLMA 0.62
  • VLY 0.22
  • MACD
  • OLMA 0.15
  • VLY -0.00
  • Stochastic Oscillator
  • OLMA 83.54
  • VLY 60.87

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About VLY Valley National Bancorp

Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.

Share on Social Networks: